FDA Investigator Harry A Wilson
Harry A Wilson has conducted inspections on 38 sites in 2 countries as of 23 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
38
Last Inspection Date:
23 May 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
France
FDA Investigators that have inspected at least one site in common with Harry A Wilson:
Amy L Mcintyre,
Andrea J Schmidt,
Andrew M Kolenc,
Antonetta M Colacchio,
Aryonna M Renouf,
Betty Kay Baxter,
Brandon K Lawson,
Brent W Higgs,
Brian P Hendrickson,
Brittany R Laymon,
Bruce W Benware,
Carla R Hinz,
Carolyn J Cook,
Cheryl D Mccall,
Christine L Williams,
Christopher M Jenner,
Ciara J Bajulai Austin,
Daniel J Lahar,
David A Gonzalez,
Debra L Curtis,
Donald R Hawn,
Edith M Gonzalez,
Elisa J Beard,
Elizabeth P Mayer,
Eric R Holm,
Eric S Myskowski,
Felix J Marrero,
Frank L Cordova,
Garrad R Poole,
Gary C Pecic, Jr,
Gerard T Schneider,
Gina M Scholze,
Gloria A Milster,
Hanna L Potter,
Holly J Smith,
Holly L Miller,
Howard A Webley,
Hung V Le,
Isabel Y Espinosa,
Isaiah D Isakson,
Jacob W Reynolds,
James D Romero,
James P Stallings,
Jamie L Port,
Janice L Straight,
Jennifer A Robinson,
Jennifer M Heitz,
Jennifer M Pouget,
Jennifer R Mathern,
Jessica I Newman,
Jessie E Morris,
Jin M Kim,
Ka L Wong,
Karen M Labounty,
Kawshalya Pathiraja,
Keith C Littrell,
Khumo A Phake,
Kibily D Dembele,
Kimberley A Hoefen,
Larisa E Pavlick,
Laura A Munsterman,
Laura B Kennedy,
Laura L Van Wagenen,
Lavender M Huskey,
Linda F Murphy,
Linda M Cheny,
Lucas B Leake,
Manuel A Moreno,
Marc A Jackson, Jr,
Margo C Jones,
Marie B Buen Bigornia,
Marion W Nadeau,
Marquez D Berrianvalle,
Mary F Bodick,
Matthew A Johnson,
Matthew J Hansen,
Meaghan M Rabideau,
Michael L Zimmerman,
Michael W Shafer,
Michelle D Motsinger,
Nathan R Moon,
Nianna C Burns,
Nianna M Capalia,
Nicholas Fragedakis,
Nora W Kabbara,
Oluwaseyi Ojinni,
Patricia A Brown,
Patricia A Maestas,
Patricia P Wrona,
Paul Z Balcer,
Randy V Bong,
Richard T Jensen,
Samantha E Rafferty,
Sara Jdent Acosta,
Secrist,
Sheila Alaghemand,
Shererk,
Solomon G Williams,
Steve P Yost,
Thanh M Andrews,
Theressa B Smith,
Timothy T Kapsala,
William A Lanier,
Zachary L Stamm
Harry A Wilson's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2023 | FDA 483 | Abbott Laboratories Inc. - Form 483, 2023-06-07 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more